VIEW
IN BROWSER
EDITOR'S
NOTE: Big4Bio newsletters will not be
published from Dec 16, 2025 to Jan 4, 2026; they
will resume distribution on Monday, Jan 5, 2026.
|
 |
|
December 12, 2025 |
| Covering
Life Sciences Drugs, Diagnostics,
Devices, Digital Health |
|
|
|
* may need subscription to view |
- AtaiBeckley: New U.S. Patent Granted for
EMP-01, Strengthening Intellectual Property
Portfolio More
- BeyondSpring: ESMO Asia Presentation on
Plinabulin + Docetaxel Improving Survival in
Large Phase 3 DUBLIN-3 Asian Subset for EGFR
WT NSCLC Compared to Docetaxel, Strengthening
the Case for a Global Registration Path More
- Glenmark Pharmaceuticals: To launch
Leucovorin Calcium for Injection USP, 350
mg/vial Single-Dose Vial More
- ImmuneWalk Therapeutics: Positive Results
From Phase 1 SAD/MAD Study of IW-601, a
First-In-Class Therapeutic With Broad
Potential in Inflammatory and Autoimmune
Diseases More
- Mesoblast: Independent Study Presented at
American Society of Hematology (ASH) Annual
Meeting Concludes Remestemcel-L Superior to
Ruxolitinib in Clinical Outcomes as Treatment
for SR-aGvHD More
- OKYO Pharma: New Data Showing Favorable
Corneal Nerve Outcomes in Phase 2 Study for
Neuropathic Corneal Pain More
- Syndax: Revuforj (revumenib) Named Best New
Drug at the Scrip Awards 2025 More
- Tharimmune: Appoints Jacob Asbury as
Chief Financial Officer to Advance Canton
Coin Treasury Strategy More
|
|
- Cosette Pharmaceuticals: Termination
of Proposed Acquisition of Mayne Pharma More
- Cycle Pharmaceuticals: To Acquire
Applied Therapeutics More
- Get
Full Access to BYTE51 Life Sciences
Intelligence for 50% Off
More
- JPM Week Conference Readiness
Packages (Big4Bio Subscriber Discount) More
- More on Biotech Venture Firm Apple
Tree Going Bankrupt Amid Disputing With
Billionaire Backer More
- Roivant Updates Investors on Mosliciguat
Development Plans More*
- Tevogen: CEO Supports Local Law Enforcement
With Personal Contribution of 230,000
Company’s Shares of Common Stock More
|
|
- BioPharmGuy News: Pre-Holiday Roast, New Flu
Dropped, Purdue Tumbles, High Energy Decision
More
- More on Priority Review for Opdivo and Chemo
in cHL More*
- Subscribe to LifeSci Startup for
Updates on US Startups More
- The Big4Bio Podcast: Every Moment
Matters: Integrating AI into Drug Discovery
Podcast
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: NYC Life Science Company
Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
|
Apply to have your company
showcased by Big4Bio. |
|
|
|
|
|
 |
| M&A
in Life Sciences: The Turning Tide
– Why Now is a Strategic
Inflection for Biopharma and
Biotech |
|
Learn More
→ |
|
|
- Centessa CEO to Step Down; John Maraganore,
Clive Meanwell Find CMO for Their New Cardio
Bet More*
- ICYMI: CEO's Perspective: Big Moves Come
with Big Responsibilities More
- ICYMI: CEO's Perspective: The High Cost of
Job Hopping More
- ICYMI: Elevating Executive Presence: A
Blueprint for Life Sciences and Biotech
Leaders More
- ICYMI: The Power of Peer Learning: Why Even
Top Biotech Leaders Need Mentorship More
- ICYMI: What’s Next in Precision Medicine:
Leadership Challenges and Opportunities More
- 9 Companies Hiring in New Jersey More
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:NYC,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
